The Tidutamab Biosimilar Anti-SSTR2 Antibody is a groundbreaking product designed for research involving the SSTR2 receptor, a key target in cancer therapy. This monoclonal antibody, produced using cutting-edge technology, specifically targets the SSTR2 receptor, which plays a crucial role in regulating tumor growth and hormone production in various cancers.Validated for use in various applications, including immunohistochemistry and flow cytometry, this antibody is highly specific and sensitive, ensuring accurate detection and analysis of SSTR2 expression in cell lines and tissue samples. Its ability to bind exclusively to the SSTR2 receptor makes it an invaluable tool for studying the role of this receptor in cancer progression and developing targeted therapies.
With its potential applications in cancer research and drug development, the Tidutamab Biosimilar Anti-SSTR2 Antibody offers researchers a powerful tool for investigating the mechanisms underlying SSTR2-mediated signaling pathways and exploring novel treatment strategies for SSTR2-expressing tumors. Stay ahead in your research with this innovative antibody designed to accelerate advances in cancer biology and therapeutics.
Product Name:
Tidutamab (Anti-SSTR2) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0106
Target:
SSTR2
Host Species:
Chimeric Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
XmAb-18087
Description:
Anti-SSTR2(tidutamab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
